The Living Guidelines: UA/NSTEMI Antiplatelet Therapy Polling Results for CLASS III Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class III Guidelines
Abciximab should not be administered to patients in whom PCI is not planned. (Level of Evidence: A)

 Antiplatelet Therapy CLASS III Recommendation should be: CLASS I CLASS IIa CLASS IIb CLASS III